Medinotec (MDNC) Cash from Investing Activities (2022 - 2026)
Medinotec's (MDNC) quarterly Cash from Investing Activities came in at -$40350.0 in Q2 2026, down 3097.77% quarter-over-quarter from $1346.0 in Q1 2025.
Analysis
Medinotec (MDNC) Cash from Investing Activities (2022 - 2026) Analysis & Trends
Medinotec (MDNC) has reported Cash from Investing Activities for 5 consecutive years, with -$40350.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities changed N/A year-over-year to -$40350.0; the trailing twelve-month figure through May 2026 stood at -$123308.0 (changed N/A YoY), and the FY2026 full-year result was -$1363.0, up 98.47% from the prior year.
- Cash from Investing Activities declined to -$40350.0 in Q2 2026 per MDNC's latest filing, from $1346.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $121562.0 in Q1 2023 and bottomed at -$621785.0 in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$67151.5 across 5 years, with a median of -$11678.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities jumped 234.24% in 2023, then tumbled 90.97% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$621785.0 in 2022, then jumped by 119.55% to $121562.0 in 2023, then sank by 159.74% to -$72626.0 in 2024, then soared by 101.85% to $1346.0 in 2025, then tumbled by 3097.77% to -$40350.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$40350.0, $1346.0, and -$72626.0 for Q2 2026, Q1 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | -40,350.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -40,350.00 |
| Feb 28, 2025 | 1,346.00 |
| Nov 30, 2024 | -72,626.00 |
| Aug 31, 2024 | -11,678.00 |
| May 31, 2024 | -6,055.00 |
| Feb 29, 2024 | 10,976.00 |
| Feb 28, 2023 | 121,562.00 |
| Nov 30, 2022 | -621,785.00 |
| Aug 31, 2022 | -9,407.00 |
| May 31, 2022 | -20,093.00 |
| Feb 28, 2022 | -90,556.00 |